Fatima Scipione

Vice President, Global Patient Affairs Blueprint Medicines

Fatima is Vice President of Global Patient Affairs at Blueprint Medicines, with over 25 years of experience transforming patient advocacy into a strategic, value-driven function within the pharmaceutical and biotech industry. She has redefined how patient insights, particularly in rare diseases and cancer, are integrated into healthcare decision-making, drug development, and commercialization strategies.

Fatima’s leadership is centered on empowering patients and fostering strong, connected communities, ensuring their voices shape meaningful advancements in medicine. She is recognized for building and leading patient-centric teams with a clear strategic vision, advancing patient care while delivering lasting impact.

A committed advocate for civic service, Fatima has advanced the mission of numerous organizations, including Cancer Support Community, Family Reach, Life Science Cares, Twist Out Cancer, International Myeloma Foundation, and Upstage Lung Cancer.

Seminars

Thursday 7th May 2026
Panel Discussion: Amplifying Patient Advocacy Impact to Drive Measurable Outcomes
10:00 am
  • Best methods for partnering with ultra rare and larger rare patient organizations that maximize measurable outcomes and build-in evaluation components
  • Collaboration on data collection from external patient advocacy initiatives without breaching compliance
  • Supporting patient engagement efforts that maximize community impact while demonstrating value to your organization
  • Understanding the value of building meaningful relationships with Patient Advocacy Organization that lead to successful outcomes for patients and your organization
Fatima Scipione, VP of Global Patient Affairs, speaking at 3rd Measuring Patient Engagement Conference